Nest#4-Nerve Excitation Control Through AC Regulation (NECTAR)
Nest#4-Nerve Excitation Control Through AC Regulation (NECTAR)
批准号:
10701822
负责人:
Tina Louise Vrabec
金额:
$89.48万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-09-10 至 2025-08-31
关键词:
Action PotentialsAreaArrhythmiaAutonomic nervous systemBronchial SpasmChargeChronicChronic Obstructive Pulmonary DiseaseCommunicationCommunitiesComplexDataDevicesDiseaseDown-RegulationElectric StimulationElectrodesEnsureFailureFiberFrequenciesFutureGoalsHeartHistologicImplantInjectionsKnowledgeLicensingMapsMeasurementMeasuresMedicalMuscleNerveNerve BlockNervous SystemNervous System controlNeural ConductionNociceptionOutputPhysiologic pulsePhysiologicalProceduresProtocols documentationPublishingRampRegulationReproducibilityResearchResearch PersonnelSafetySpeedSphincterSystemTechniquesTestingTherapeuticTherapeutic EffectTimeTranslationsWidthWorkbioelectronicschronic neuropathic painclinical applicationin vivomultimodalityneuralneuroregulationopen sourcepreventresearch studyspasticitytoolurinaryvoltageweb site
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Control of physiological systems via the autonomic nervous system is often based on a baseline of tonic
neural activity that is modulated to achieve a desired state. Electrical stimulation can be used to increase, or
upregulate, this activity, but until recently, there was no reliable means to rapidly and reversibly decrease, or
downregulate, this activity. The ability to downregulate, or completely block, neural activity could apply to a wide
range of clinical applications and new treatments, including: downregulation of sympathetic drive to the heart for
arrhythmias, block of bronchopulmonary parasympathetic nerves to reverse the bronchospasm in chronic
obstructive pulmonary disease (COPD), block of nociceptive fibers to alleviate chronic neuropathic pain, and
block of spastic urinary sphincter muscles to enable voiding, etc. Kilohertz frequency alternating current (KHFAC)
has been demonstrated as a way to provide nerve block in a quick acting, titratable, and rapidly reversible
manner. The goal of the NECTAR project is to create the tools necessary to allow researchers to incorporate
reversible electrical nerve block via KHFAC into their research in a practical, effective, and safe manner.
KHFAC nerve block has two key features that distinguish it from non-electrical nerve block. First, KHFAC
nerve block occurs instantly. Second, KHFAC nerve block is fully and rapidly reversible. Unfortunately, research
in the area of nerve block has been hampered by a lack of commercially available nerve block devices.
Successful application of KHFAC block requires knowledge of the specific waveform parameters for effective
and safe use of these waveforms in neural control. The therapeutic effect of KHFAC is complex and multimodal
resulting in suboptimal results from improperly tuned waveform parameters. The contribution of the NECTAR
project will be to provide two critical deliverables related to KHFAC block: 1) a fully featured device with
reproducible outputs and 2) comprehensive mapping of the KHFAC parameter space.
In aim one, a KHFAC module will be produced that will include many key features such as amplitude/
frequency ramping, validated outputs, DC offset mitigation, and charge injection capacity (CIC) electrode testing.
In aim two, we will perform chronic in vivo studies to provide data that establishes the therapeutic window for
KHFAC block with respect to frequency, amplitude, charge delivery, and duty cycle. These studies will involve
both functional and histological metrics for safety and efficacy.
Electrical block, when combined with electrical stimulation, can provide real-time control of neural activity, in
which action potentials can be variably upregulated or downregulated as needed; a significant advantage for
many bioelectronic applications. With the completion of Aims 1 and 2, the NECTAR project will enable the
bioelectronic research community to rapidly proceed with incorporation of KHFAC electrical nerve block into their
research studies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Minimally Invasive On Demand Electrical Nerve Block (OD-ENB) Device for Peripheral Pain
-
批准号:10482175
-
项目类别:
-
资助金额:$26.04万
-
财政年份:2023
-
负责人:Tina Louise Vrabec
-
依托单位:
Nest#4-Nerve Excitation Control Through AC Regulation (NECTAR)
-
批准号:10549471
-
项目类别:
-
资助金额:$66.73万
-
财政年份:2022
-
负责人:Tina Louise Vrabec
-
依托单位:
Investigation of Partial Electrical Nerve Block for Autonomic Regulation
-
批准号:10323259
-
项目类别:
-
资助金额:$46.06万
-
财政年份:2020
-
负责人:Tina Louise Vrabec
-
依托单位:
Investigation of Partial Electrical Nerve Block for Autonomic Regulation
-
批准号:10080757
-
项目类别:
-
资助金额:$46.06万
-
财政年份:2020
-
负责人:Tina Louise Vrabec
-
依托单位:
Investigation of Partial Electrical Nerve Block for Autonomic Regulation
-
批准号:10542814
-
项目类别:
-
资助金额:$40.83万
-
财政年份:2020
-
负责人:Tina Louise Vrabec
-
依托单位:
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
-
批准号:2021JJ40433
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:孙磊
-
依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
-
批准号:32001603
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:段真珍
-
依托单位:
AREA国际经济模型的移植.改进和应用
-
批准号:18870435
-
项目类别:面上项目
-
资助金额:2.0万元
-
批准年份:1988
-
负责人:史树中
-
依托单位: